Vendas Alterar Data
Agenus USD 33.7M 500K 2026-03
Amgen USD 10.4B 300M 2026-09
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 450.82M 375.59M 2026-09
Baxter International USD 2.98B 20M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Enviri Corporation USD 555M 19.81M 2025-12
Gilead Sciences USD 8.3B 500M 2026-09
GlaxoSmithKline GBP 8.89B 480M 2026-09
Glaxosmithkline GBP 8.89B 1.2B 2026-09
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 524.42M 98.93M 2026-09
Intrexon USD 717K 511K 2024-06
Ionis Pharmaceuticals USD 243M 25M 2026-09
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Ligand Pharmaceuticals USD 78.75M 4.95M 2026-09
MacroGenics USD 32.83M 12.03M 2026-06
Merck USD 18.1B 1.5B 2026-09
Pfizer USD 16.6B 1.57B 2026-09
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Veracyte USD 151.75M 1.43M 2026-09